A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis
Authors:
- Roberta Goncalves MarangoniRMRoberta Goncalves Marangoni
- Benjamin D KormanBKBenjamin D Korman
- Yannick AllanoreYAYannick Allanore
- Philippe DieudePDPhilippe Dieude
- Loren L ArmstrongLALoren L Armstrong
- Margarita RzhetskayaMRMargarita Rzhetskaya
- Monique HinchcliffMHMonique Hinchcliff
- Mary CarnsMCMary Carns
- Sofia PodluskySPSofia Podlusky
- Sanjiv J ShahSSSanjiv J Shah
- Barbara RuizBRBarbara Ruiz
- Eric HachullaEHEric Hachulla
Open Access
- 19 May 2015
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 17 (1) , 1-8
Abstract
Introduction: The multifunctional nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) has potent anti-fibrotic effects, and its expression and activity are impaired in patients with systemic sclerosis (SSc). We investigated PPAR-γ gene (PPARG) single nucleotide polymorphisms (SNPs) associated with SSc. Methods: Tag SNPs spanning PPARG were genotyped in a European ancestry US discovery cohort comprising 152 SSc patients and 450 controls, with replication of our top signal in a European cohort (1031 SSc patients and 1014 controls from France). Clinical parameters and disease severity were analyzed to evaluate clinical associations with PPARG variants. Results: In the discovery cohort, a single PPARG intronic SNP (rs10865710) was associated with SSc (p = 0.010; odds ratio = 1.52 per C allele, 95% confidence interval 1.10-2.08). This association was replicated in the French validation cohort (p = 0.052; odds ratio = 1.16 per C allele, 95% confidence interval 1.00-1.35). Meta-analysis of both cohorts indicated stronger evidence for association (p = 0.002; odds ratio = 1.22 per C allele, 95% confidence interval 1.07-1.40). The rs10865710 C allele was also associated with pulmonary arterial hypertension in the French SSc cohort (p = 0.002; odds ratio = 2.33 per C allele, 95% confidence interval 1.34-4.03). Conclusions: A PPARG variant is associated with susceptibility to SSc, consistent with a role of PPAR-γ in the pathogenesis of SSc.Keywords
This publication has 54 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-upHuman Molecular Genetics, 2012
- A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populationsHuman Molecular Genetics, 2011
- HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variantsNucleic Acids Research, 2011
- Integrating common and rare genetic variation in diverse human populationsNature, 2010
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusNature Genetics, 2010
- SCAN: SNP and copy number annotationBioinformatics, 2009
- Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-γBiochemical and Biophysical Research Communications, 2008
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994